Cetera Advisors’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$2.21M Buy
149,574
+135,929
+996% +$1.88M 0.02% 774
2023
Q4
$195K Buy
13,645
+3,394
+33% +$48.2K ﹤0.01% 1653
2023
Q3
$143K Buy
+10,251
New +$131K ﹤0.01% 1573
2018
Q4
Sell
-10,609
Closed -$244K 949
2018
Q3
$244K Sell
10,609
-3,807
-26% -$86.3K 0.01% 809
2018
Q2
$312K Sell
14,416
-3,027
-17% -$59.1K 0.02% 652
2018
Q1
$309K Sell
17,443
-7,478
-30% -$132K 0.02% 593
2017
Q4
$467K Sell
24,921
-4,153
-14% -$82.6K 0.03% 453
2017
Q3
$638K Buy
29,074
+7,914
+37% +$179K 0.04% 403
2017
Q2
$505K Buy
21,160
+6,197
+41% +$158K 0.03% 459
2017
Q1
$419K Sell
14,963
-12,375
-45% -$324K 0.03% 487
2016
Q4
$669K Sell
27,338
-2,187
-7% -$50.1K 0.05% 346
2016
Q3
$745K Sell
29,525
-779
-3% -$18.7K 0.06% 320
2016
Q2
$620K Buy
30,304
+5,100
+20% +$106K 0.05% 367
2016
Q1
$506K Buy
25,204
+4,148
+20% +$79.5K 0.04% 399
2015
Q4
$424K Buy
21,056
+5,106
+32% +$108K 0.04% 441
2015
Q3
$371K Buy
+15,950
New +$407K 0.04% 432

Other funds holding SBRA

Cetera Advisors's SBRA Position: Q1 2024 in Review

Cetera Advisors increased its Sabra Healthcare REIT (SBRA) stake by 996% in Q1 2024, buying an estimated $1.88M and bringing the position to 149,574 shares worth $2.21M. The position accounts for 0.02% of the portfolio, ranked #774.

Cetera Advisors first reported a position in SBRA in Q3 2015 and has held it in 16 quarters since. 342 funds tracked by Wall St. Rank hold SBRA as of Q1 2024.

  • Cetera Advisors held 149,574 shares of Sabra Healthcare REIT worth $2.21M as of Q1 2024.
  • Cetera Advisors bought 135,929 Sabra Healthcare REIT shares in Q1 2024, an estimated $1.88M.
  • Sabra Healthcare REIT made up 0.02% of Cetera Advisors's portfolio in Q1 2024, its #774 holding.
  • Cetera Advisors first reported a position in Sabra Healthcare REIT in Q3 2015 and has held it in 16 quarters since.
  • 342 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q1 2024.

Based on Cetera Advisors's 13F filing for Q1 2024, filed 15 May 2024.